Scientists at the University of Medicine and Dentistry of New Jersey have found that children with autism are unable to metabolize “good” fatty acids due to the absence of a key gene, called GSTM1.

The potential treatment is a kind of “therapeutic cocktail” tailored to each child, which would give them a dose of a “good” fatty acid that they are not able to make on their own.